Logo
  • Blog Slide
  • Blog Slide
  • Blog Slide

Archive for November 7th, 2012

Learn More About TMS For Depression

Tms for depression

TMS was recently approved by the FDA to treat major depressive disorder, specifically for patients who have treatment resistant depression. Although numerous antidepressants and other treatments are available, many patients suffer multiple depressive episodes that are not well controlled with existing treatments. Approximately 1/3 of patients treated with conventional antidepressants fail to achieve remission and show signs of treatment resistant depression. Many patients suffer from side effects to commonly used antidepressants, such as nausea, weight gain, insomnia, sedation, emotional blunting and sexual dysfunction.

Neurostar TMS for depression therapy is a non-invasive, non-systemic procedure that has been extensively studied for the treatment of depression. TMS for depression was approved by the USFDA in 2008 for the treatment of Major Depressive Disorder in adults who have treatment resistant depression. TMS for depression involves placing a coil on the scalp that generates a magnetic field to stimulate targeted neurons, which can help to alleviate symptoms. Neurostar TMS for depression is a safe and effective outpatient procedure performed in a physician’s office with each treatment lasting about 40 minutes daily for 4 to 6 weeks. Neurostar TMS for depression addresses the unmet needs in psychiatry for a more effective treatment.

The treatment coil is applied gently to the head above the left prefrontal cortex. This part of the brain is involved with mood regulation, and therefore is the location where the magnetic fields are focused. These magnetic fields do not directly affect the whole brain; they only reach about 2-3 centimeters into the brain directly beneath the treatment coil. As these magnetic fields move into the brain, they produce very small electrical currents. These electrical currents activate cells within the brain which are thought to release neurotransmitters like serotonin, norepinephrine, and dopamine to treat depression.

NeuroStar TMS for depression therapy was evaluated for efficacy and safety in the treatment of Major Depressive Disorder in patients who have treatment resistant depression. The research shows that approximately 1 in 2 patients treated with TMS for depression experienced significant improvement in their symptoms of depression. In addition approximately 1 in 3 patients experience complete relief from symptoms.

TMS for depression therapy does not cause side effects such as weight gain, sedation, or sexual dysfunction like many antidepressants. Also, TMS for depression has no memory impairment which is a common side effect of Electroconvulsive Therapy. Find out more today about treating treatment resistant depression with safer methods such as TMS.

Breast Augmentation Tampa Has To Offer

Breast implants in clearwater

If you are interested in breast augmentation tampa has several clinics that can meet your needs. You will need to research one of these clinics before you visit them. You will want to make sure that you can trust your surgeon. Trusting your surgeon when it comes to breast augmentation Tampa has to offer is very important for clients, especially if you are new to this type of care.

The reasons for breast augmentation tampa residents have are different for each client. If you know someone that has had breast augmentation done in the area, speak with that person and learn more about where they went for their operation. You may hear a horror story about a breast augmentation gone wrong, or you may hear about a clinic that provided excellent care leading up to the surgery as well as excellent care afterwards.

Medical Mission Trips

Thanks for visiting our site. We bring you news, weather and financial information for the medical field. Take a look around and you will certainly find something that interests and helps you.

Travel Medically

 
Ashburn, Va



Sorry! No actual weather data available!


Health News

Finance

error : cannot receive stock quote information